This website is available in:
To change websites, find a country in the A - Z list then choose a language.
To change websites, click on the map pins to find a country then choose a language.
HomeLife SciencesBiopharmaceutical ServicesClinical Research ServicesClinical PharmacologyFirst-In-Human (FIH) Clinical Trials
We provide you with the largest EU facilities for conducting first-in-human clinical trials (FIH) and Phase I clinical studies with healthy volunteers. In the last six years, we have been trusted by major global organizations to perform 500 trials, of which a third were FIH clinical trials.
We conduct both simple and complex FIH studies such as:
Our combined protocols study design strategy provides a bundle of studies quickly approved by health authorities and ethics committees. That means you will rapidly get critical decision-making data from your FIH studies.
In a first-in-human study, our services enabled our client to carry out the dose review, and make the decision to go to the next dosing level within one week, due to timely combination of:
Contact us today to learn how we can help with your early phase, first-in-human clinical trial program.